Weight-loss drugs avoid Wada ban list for 2027 but to remain monitored The Independent 5d Article paywall
Fifth circuit upholds FDA GLP-1 shortage decisions, narrowing path for mass-market compounding JD Supra 5d Mounjaro Ozempic All sources
Popular GLP-1 weight-loss drugs linked to potentially deadly brain disorder Fox News 2d Diet and Fitness Global Health Science All sources
Eli Lilly stock gains as retatrutide and Foundayo data highlight pipeline strength Benzinga 14h Obesity Diabetes Health & Fitness Article paywall
